Last reviewed · How we verify
Heart Failure drugs — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
Heart Failure drugs (Heart Failure drugs) — Ege University.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Heart Failure drugs TARGET | Heart Failure drugs | Ege University | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Heart Failure drugs CI watch — RSS
- Heart Failure drugs CI watch — Atom
- Heart Failure drugs CI watch — JSON
- Heart Failure drugs alone — RSS
Cite this brief
Drug Landscape (2026). Heart Failure drugs — Competitive Intelligence Brief. https://druglandscape.com/ci/heart-failure-drugs. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab